BOSTON, MA -- (Marketwired) -- 11/08/17 -- Real world evidence is poised to play a growing…
Continue ReadingTag: drug-development
Cardiovascular Drug Approval Rate in the U.S. Fell as Development Time Rose, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 09/12/17 -- Although the rate at which investigational drugs received marketing…
Continue ReadingAbuse-Deterrent Opioid Development and Uptake Are Tied to Efficacy and Regulatory/Payer Policies, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 07/13/17 -- Although 10 new opioid products with abuse-deterrent formulations (ADF)…
Continue ReadingCost to Develop and Win Marketing Approval for a New Drug Is $2.6 Billion, According to the Tufts Center for the Study of Drug Development
BOSTON, MA -- (Marketwired) -- 11/18/14 -- Developing a new prescription medicine that gains marketing approval,…
Continue ReadingADVISORY – Tufts CSDD to Disclose Cost of Developing a New Drug at Nov. 18 Briefing
BOSTON, MA -- (Marketwired) -- 11/10/14 --Tufts Center for the Study of Drug Development, Tufts University,…
Continue ReadingGlobal Companion Biomarker Market to Catapult to $319 Million by 2018
NEW YORK, NY -- (Marketwired) -- 08/15/13 -- TriMarkPublications.com cites in its newly published " in…
Continue Reading